HomeBracco Diagnostics Inc.

Bracco Diagnostics Inc.

ProHance (Gadoteridol) Injection, 279.3 mg/mL, For Pediatric Patients Younger Than Two Years Receives FDA Approval

ProHance was previously approved for this use in patient populations over the age of two.